The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Lovenberg Walter M Phd since 2006.
The trader's CIK number is 1213100.
At the time of the last reporting, Lovenberg Walter M Phd was the Director of Merrimack Pharmaceuticals Inc. (stock ticker symbol MACK).
Also see all insider trading activities at Merrimack Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | MACK | 1,428 | $9,996 | 0 | $0 | 5,462 | $11,961 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | OSIP | 0 | $0 | 20,000 | $693,778 | 20,000 | $130,000 |
| 2006 | OSIP | 0 | $0 | 2,155 | $71,168 | 7,665 | $70,901 |
1. Merrimack Pharmaceuticals Inc (MACK)
2. Osi Pharmaceuticals Inc (OSIP)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-04-25 | MACK | Option Ex | 5,462 | 2.19 | 11,961 |
| 2012-04-03 | MACK | Buy | 1,428 | 7.00 | 9,996 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-03-01 | OSIP | Option Ex | 6,668 | 6.50 | 43,342 |
| 2007-03-01 | OSIP | Sale | 6,668 | 34.07 | 227,158 |
| 2007-02-05 | OSIP | Option Ex | 6,666 | 6.50 | 43,329 |
| 2007-02-05 | OSIP | Sale | 6,666 | 35.00 | 233,310 |
| 2007-01-16 | OSIP | Option Ex | 6,666 | 6.50 | 43,329 |
| 2007-01-16 | OSIP | Sale | 6,666 | 35.00 | 233,310 |
| 2006-03-10 | OSIP | Option Ex | 7,665 | 9.25 | 70,901 |
| 2006-03-10 | OSIP | Sale | 2,155 | 33.02 | 71,168 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lovenberg Walter M Phd (Director of Merrimack Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.